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Abstract
Purpose: Computed tomography remains the first-choice modality for assessment of colorectal cancer liver metastases 
(CRLM). Dual-energy computed tomography (DECT) is a relatively new technique that is becoming increasingly 
available. One of the advantages of DECT is the ability to maximise iodine detection. Our aim was to test whether 
single-source, fast kVp-switching DECT can improve imaging quality of CRLM compared to conventional (poly-
chromatic) CT.
Material and methods: Twenty consecutive patients were enrolled into a preliminary prospective study. The scanning 
protocol consisted of four phases: non-contrast with standard 120 kV tube voltage and three post-contrast phases 
with rapid voltage switching. As a result, three sets of images were reconstructed: pre- and postcontrast polychro-
matic (PR), monochromatic (MR), and iodine concentration map (IM). To compare the sensitivity of the tested 
reconstructions, the number of CRLMs and the maximum diameter of the largest lesion were calculated. Objective 
image quality was measured as signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR). The radiation dose 
was expressed as CTDIvol.
Results: Imaging was successfully performed in all patients. The number of detected lesions was significantly lower 
on PR images than on IM and MR 50-70 keV (mean number: 4.20 and 4.45, respectively). IM and MR at 70 keV 
presented the highest quality. SNR was significantly higher for IM and 70 keV images than for other reconstructions.  
The mean radiation dose was 14.61 mGy for non-contrast 120 kV scan and 17.89 mGy for single DECT scan (p < 0.05).
Conclusions: DECT is a promising tool for CRLM imaging. IM and low-photon energy MR present the highest dif-
ferences in contrast between metastases and the normal liver parenchyma.
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Introduction
Colorectal cancer (CRC) is the third most common malig-
nancy and the fourth leading cause of cancer-related death 
worldwide [1]. Each year, 1.36 million new cases of CRC 
are diagnosed, affecting 17.2 per 100,000 people. Approxi-
mately 25% of patients present with metastases at the time 
of diagnosis, with the liver being most commonly affected 
by metastatic lesions. Moreover, almost a half of patients 
with CRC will develop metastases during treatment [2]. 
Since both the location and number of metastases are cru-
cial for surgical resection, preoperative liver imaging is of 
great importance [3-6]. Detailed presentation of lesions is 
important when precisely targeted methods of treatment are 
intended to be used, including laparoscopy, percutaneous 
ablation, chemoembolisation, and radioembolisation [7-9].
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Currently, contrast-enhanced computed tomography 
(CT) and magnetic resonance imaging (MRI) are the most 
commonly used modalities for preoperative imaging of 
colorectal liver metastasis (CRLM), with sensitivity rates of 
70-86% and specificity rates of 93-95% [5,6]. Newer MRI 
techniques, including MR elastography, are still a work in 
progress [10]. Although conventional ultrasonography 
(US) is of limited value for detecting CRLM [11], recent 
studies suggest that contrast-enhanced US (CEUS), in-
traoperative US (IOUS), and intraoperative contrast-en-
hanced US (CEIOUS) may have better performance, with 
sensitivity and specificity of up to 94% and 77%, respec-
tively [12-14]. Fluorodeoxyglucose positron emission 
tomography (FDG-PET) and FDG-PET/CT are usually 
performed only in patients after adjuvant or neoadjuvant 
chemotherapy. However, the sensitivity and specificity of 
FDG-PET/CT in naive patients are as high as 97% [5]. 
Despite its limited diagnostic performance, CT remains 
the first-choice modality for liver metastases screening in 
patients with CRC, preoperative estimation of the remnant 
liver size, and defining vascular anatomy [15]. Dual-energy 
CT (DECT) is a promising technique that can increase the 
diagnostic accuracy of CT in detecting CRLM because it 
allows material decomposition [16] and mapping of iodine 
uptake in hepatic lesions [17]. Moreover, DECT has been 
shown to improve image contrast in suboptimal contrast 
conditions [18]. Since CRLMs are usually hypovascular, 
dual-energy techniques may significantly increase the sen-
sitivity of CT in detecting these lesions. 
In this study, we aimed to test whether single-source 
fast kVp-switching DECT can improve imaging quality 
of colorectal liver metastases compared to conventional 
polychromatic CT.
Material and methods
Patients 
A total of 20 consecutive patients (11 men and nine wom-
en, aged 33-79 years [mean age 62 years] were enrolled 
between January and July 2016 into this preliminary pro-
spective study. We included patients who were scheduled 
for partial hepatectomy due to CRLM. Exclusion criteria 
were as follows: age below 18 years, pregnancy or lacta-
tion, metallic implants in the abdomen, and contraindi-
cations to iodinated contrast media. Informed consent 
was obtained from all participants, and the study was ap-
proved by our University Review Board.
DECT scanning protocol 
Examinations were performed with a Discovery CT 
750HD scanner (GE Healthcare, Waukesha, USA) using 
a dual-energy spectral CT in a GEM technology (Gem-
stone Spectral Imaging). It is a DECT technique based on 
rapid switching between high- and low-energy photon 
emission from a single source [19]. Tube voltage switching 
between 80 and 140 kV enabled reconstruction of poly-
chromatic (conventional) images at peak 140 kVp, virtual 
monochromatic images at photon energies ranging from 
40 to 140 keV, and calculation of tissue iodine concentra-
tion maps. 
A four-phase CT protocol was performed, which 
consisted of a non-enhanced phase (NP), arterial phase 
(AP), portal venous phase (PP), and venous phase (de-
layed phase, VP). The scan range was from the dome of 
the liver to the iliac crest during an inspiration. NP scans 
were acquired with a tube voltage of 120 kVp, detector 
collimation of 0.625 × 64 mm, rotation speed of 0.6 s, 
and helical pitch of 1.375:1. Then, a non-ionic contrast 
medium (Ultravist 300, Bayer Pharma AG, Germany) 
was administered intravenously with a power injector at 
3 ml/s (total dose of 1 ml/kg) followed by a 20-ml bolus 
of 0.9% NaCl at 3 ml/s. Delay times for each of the phas-
es were as follows: AP – 30 s, PP – 60 s, and VP – 180 s 
after contrast agent injection. Contrast-enhanced phases 
were acquired in the GSI scanning mode using the follow-
ing scan parameters: tube voltage switching between 80 
and 140 kVp within 0.5 ms, detector collimation of 
0.625 × 64 mm, rotation speed of 0.6-0.8 s, and helical 
pitch of 1.375:1. ASIR (Adaptive Statistical Iterative Re-
construction) option was disabled.
Image reconstruction and analysis
Post-processing was performed on a dedicated worksta-
tion (AW4.6, GE Healthcare, Waukesha, USA). The re-
constructed slice thickness was 1.25 mm. Three types of 
images were generated, including a classic polychromatic 
reconstruction at 140 kVp (PR, Figure 1), monochromatic 
virtual reconstruction (MR) at photon energies ranging 
from 40 keV to 140 keV (10-keV interval, 11 sets of im-
ages), and iodine over water maps (IM, Figure 2). In total, 
13 sets of axial images were evaluated for each patient. 
Images were assessed by two radiologists (each with 
five years of experience in abdominal CT) [10]. Subjective Figure 1. A large metastasis in segment 4a in polychromatic reconstruction
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image quality of the conspicuity of metastases was rated 
as follows: 1 – excellent, 2 – good, 3 – poor, 4 – invisible. 
Objective image quality was measured as signal-to-noise 
ratio (SNR) and contrast-to-noise ratio (CNR). The ratios 
were calculated based on the portal phase of contrast- 
enhanced images using attenuation standard deviation 
of visceral adipose tissue as the noise value (N), CT num-
ber of the major lesion as the signal value (S), and the 
difference in CT numbers between the normal liver pa-
renchyma and the major lesion as the contrast value (C). 
To compare the sensitivities of the tested reconstructions, 
the number of CRLMs and the largest diameter of the 
largest lesion were determined. 
The appearance of CRLM was compared between dif-
ferent reconstructions based on CT numbers of the larg-
est lesion. In the first step, the lesion was identified on 
polychromatic portal phase images, and a circular region 
of interest (ROI) was placed to cover the largest possible 
cross-sectional area of the metastasis. Then, the ROI was 
propagated to all other phases and reconstructions cor-
rected manually if necessary. CT numbers were measured 
on polychromatic and monochromatic images. Iodine 
concentration (µg/cm3) was measured on iodine maps. 
Statistical analysis 
Parametric data were expressed as mean values with 95% 
confidence intervals (95% CI). Radiation dose was ex-
pressed as CTDIvol. The reference diameter and the num-
ber of lesions were assessed on PR images. The normal-
ity of data was assessed using the Kolmogorov-Smirnov 
test. Repeated measures analysis of variance (ANOVA) 
was used to test for potential differences between recon-
structions in the subjective image quality, the number of 
lesions, and the diameter of the largest metastasis. Dif-
ferences between reconstructions were tested using the 
Friedman test or the repeated measures ANOVA test. 
The intraclass correlation coefficient was used to test in-
terobserver agreement with respect to the number of le-
sions and the size of the largest lesion. A p value < 0.05 
was considered significant. Statistical analyses were per-
formed using Statistica 10 (StatSoft Inc., Tulsa, OK) and 
MedCalc Statistical Software version 13.3 (MedCalc Soft-
ware bvba, Ostend, Belgium).
Results
Imaging was successfully performed in all patients, 
and no adverse reactions were observed. None of the ex-
aminations was rejected due to inadequate image quali-
ty. The mean radiation dose was 14.61 mGy for NP and 
17.89 mGy for DECT phases, respectively (p < 0.05). 
The results of the image quality analysis are present-
ed in Table 1. The highest subjective image quality was 
rated for monoenergetic reconstructions at 120, 130, and 
140 keV (p < 0.0001). The diameter of metastases ranged 
between 12 and 193 mm (mean diameter: 58.4, 95% CI: 
34.3-82.4 mm). The Friedman test revealed significant 
differences between reconstructions (p = 0.0070), but in 
post-hoc analysis there was no discrepancy between PR 
and monoenergetic images. The number of lesions varied 
between 1 and 20 mm (mean size: 4.20, 95% CI: 1.37-7.03 
mm); the Friedman test revealed significant differences 
between reconstructions (p = 0.0495). The post-hoc anal-
ysis showed that the number of lesions was significantly 
lower on PR images than on IM and on monoenergetic 
reconstructions at 50, 60, and 70 keV (mean number: 4.20 
and 4.45, respectively). As regards the objective assess-
ment, IM and monoenergetic reconstruction at 70 keV 
presented the highest quality. SNR was significantly high-
er for IM and 70 keV images than for other reconstruc-
tions. Differences in CNR were less pronounced, as the 
only significant difference was observed between 70 keV 
images and polychromatic reconstructions.
Figure 2. The metastasis presented in Figure 1 in iodine map (IM) and monoenergetic reconstructions at 40-140 keV
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Attenuation values of the normal liver parenchyma and 
those of metastases are presented in Table 2 and Figure 3. 
These values were statistically different between the tested 
reconstructions (p < 0.001). The relative difference in at-
tenuation (or iodine content) between the liver parenchy-
ma and the largest lesion is presented in Figure 4. In the 
arterial phase, the difference was the highest for IM (mean 
58%, 95% CI: 32-83%). There was a significant within-re-
construction effect in ANOVA (p = 0.005), and IM val-
ues were significantly higher than PR values (p = 0.0488). 
The highest difference in the portal phase was observed 
for IM (mean 51%, 95% CI: 35-68%) and in the venous 
phase for 140 keV (mean 33%, 95% CI: 20-47%), with no 
significant within-reconstruction effects (Figure 5).
The interobserver agreement for the number of lesions 
was high. It was the lowest for PR (ICC 0.95, 95% CI: 
0.88-0.98), followed by monoenergetic reconstructions at 
40 keV (ICC 0.96, 95% CI: 0.90-0.99). The remaining re-
constructions presented an ICC of 0.99. The interobserver 
agreement for the diameter of the largest lesion was 0.99 
(0.99-1.00) for all reconstructions.
Discussion
To our knowledge, this is the first study to analyse the 
technical quality of single-source, fast kVp-switching 
DECT in the imaging of CRLM. The main finding of our 
study is that some monoenergetic reconstructions may re-
Table 1. Image quality parameters for the assessed reconstructions. Mean values and 95% CIs are given 
Image quality score No. of lesions Largest lesion diameter (mm) SNR CNR
IM 2.80 (2.51-3.09) 4.45 (1.56-7.36) 58.6 (34.6-82.6) 3.40 (2.63-4.20) 2.06 (1.37-2.55)
PR 2.10 (1.70-2.50) 4.20 (1.37-7.03) 58.2 (34.0-82.5) 2.48 (1.95-3.02) 1.34 (0.91-1.77)
MR40 1.95 (1.59-2.31) 4.10 (1.27-6.93) 57.3 (33.3-81.3) 2.91 (2.24-3.58) 1.99 (1.28-2.69)
MR50 1.50 (1.26-1.74) 4.45 (1.55-7.35) 58.5 (34.5-82.6) 2.91 (2.25-3.57) 1.86 (1.20-2.52)
MR60 1.55 (1.23-1.87) 4.45 (1.55-7.35) 58.1 (34.2-82.0) 3.06 (2.32-3.81) 2.08 (1.38-2.78)
MR70 1.70 (1.36-2.04) 4.45 (1.55-7.35) 58.3 (34.5-82.2) 3.41 (2.60-4.23) 1.91 (1.27-2.54)
MR80 2.10 (1.70-2.50) 4.35 (1.50-7.20) 58.5 (34.5-82.4) 2.83 (2.16-3.50) 1.51 (1.04-1.98)
MR90 2.20 (1.84-2.56) 4.35 (1.50-7.20) 58.6 (34.7-82.5) 2.72 (2.03-3.41) 1.42 (0.99-1.86)
MR100 2.35 (1.97-2.73) 4.30 (1.45-7.15) 58.2 (34.3-82.2) 2.63 (1.94-3.32) 1.33 (0.92-1.74)
MR110 2.40 (2.02-2.78) 4.25 (1.39-7.11) 57.6 (33.5-81.7) 2.57 (1.88-3.26) 1.25 (0.86-1.65)
MR120 2.65 (2.34-2.96) 4.30 (1.44-7.16) 58.0 (34.0-82.1) 2.51 (1.82-3.19) 1.43 (0.98-1.88)
MR130 2.80 (2.51-3.09) 4.25 (1.43-7.07) 57.9 (33.8-82.1) 2.47 (1.79-3.14) 1.14 (0.76-1.53)
MR140 2.80 (2.51-3.09) 4.15 (1.31-6.99) 57.4 (33.3-81.5) 2.27 (1.54-3.01) 1.25 (0.56-1.94)
SNR – signal-to-noise ratio, CNR – contrast-to-noise ratio, IM – iodine maps, PR – polychromatic reconstructions, MR – monochromatic reconstructions
Table 2. Mean attenuation values at arterial, portal, and venous phases of contrast enhancement of the normal liver parenchyma and the metastatic lesions 
as assessed by different reconstructions
Normal liver Metastases
Arterial phase Portal phase Venous phase Arterial phase Portal phase Venous phase
IM 6.0 21.7 13.1 8.0 16.3 13.2
PR 59.8 83.4 71.3 8.0 16.3 13.2
MR40 98.1 212.9 149.9 49.8 62.0 59.9
MR50 79.2 155.0 111.8 97.5 160.0 139.3
MR60 67.2 116.3 88.0 74.0 112.8 100.5
MR70 60.1 92.2 73.4 60.8 83.4 76.8
MR80 55.7 76.8 62.9 50.9 66.1 62.0
MR90 52.7 67.4 58.3 44.5 54.9 52.9
MR100 50.6 59.8 54.0 40.9 46.5 46.0
MR110 49.1 54.8 50.8 38.3 41.2 42.2
MR120 48.0 51.3 48.9 37.7 38.0 39.1
MR130 47.2 48.6 47.2 35.1 34.8 37.0
MR140 46.6 46.5 45.9 34.1 32.8 35.3
IM – iodine maps, PR – polychromatic reconstructions, MR – monochromatic reconstructions
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veal more metastases than polychromatic reconstructions. 
Moreover, iodine maps showed a higher signal difference 
between lesions and the normal liver parenchyma than 
did conventional CT images.
DECT may be used to improve the image quality of 
CT of the liver. Recently, Sudarski et al. compared objec-
tive and subjective image quality of PR and MR for GIST 
liver metastases. They found that less experienced readers 
might improve their diagnostic confidence in evaluating 
metastases by using 70 keV MR instead of conventional 
PR, because MR images at 70 keV were given the highest 
subjective quality ratings regardless of patient size [20]. In 
our study, the highest subjective image quality was rated 
for reconstructions at 120, 130, and 140 keV, but images 
at 60 keV and 70 keV presented the highest values of SNR 
and CNR among MRs. However, in view of the study by 
Nattenmüller et al., the added value of DECT for the im-
aging of the liver is not clear [21]. Those authors tried to 
verify the role of DECT in depicting hypodense liver me-
Figure 3. Signal intensity (HU equivalent) of the normal liver parenchyma (A) and the largest metastasis (B) in arterial, portal, and venous phases of contrast 
enhancement for the tested image reconstructions (IM – iodine maps, PR – polychromatic reconstruction, and monoenergetic reconstructions at 40-140 keV)
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Figure 4. Relative difference in the signal intensity (HU equivalent) of 
the normal liver parenchyma and the largest metastasis in arterial, portal, 
and venous phases of contrast enhancement for the tested image recon-
structions (IM – iodine maps, PR – polychromatic reconstruction, and 
mono energetic reconstructions at 40-140 keV)
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Figure 5. Relative difference in the signal intensity (HU equivalent) of 
the normal liver parenchyma and the largest metastasis in arterial, portal, 
and venous phases of contrast enhancement for iodine maps (IM), poly-
chromatic reconstruction (PR), and monoenergetic reconstruction at 40 keV
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tastases within steatotic liver parenchyma. Although they 
found that MR images at 120 kVp had the best quantitative 
and qualitative parameters, they concluded that additional 
radiation exposure due to dual-energy acquisition is not 
clinically justified. On the other hand, our results indicate 
that DECT is characterised by improved lesion detection 
on MRs, which is a significant practical advantage. Similar 
results were presented by Altenbernd et al., who evaluated 
CRLM using just two MRs (80 keV and 120 keV) with 
nine different window settings [22]. They concluded that 
80 kVp images were more precise in detecting liver metas-
tases than 120 kVp images and that window settings had 
a significant influence on conspicuity. Specifically, MR 
at 80 keV and the 50/350 HU window setting revealed 
a significantly higher total number of metastases and 
a higher number of small metastases (< 1 mm in size) 
than 120 keV reconstructions.
As shown in Figure 3, signal intensity of the normal 
liver parenchyma and metastases is not distributed uni-
Arterial Portal Venous Arterial Portal Venous
Arterial Portal Venous IM PR 40×
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formly, with higher CT values in low-energy reconstruc-
tions. Similar spectral curves were presented by Wang et al. 
[23]. They also concluded that the best presentation of liver 
tumours is achieved in the portal venous phase because 
of improved contrast agent dispersion in comparison to 
the arterial phase. According to our results, this observa-
tion is accurate for both monoenergetic and polyenergetic 
reconstructions. However, on iodine maps, the difference 
in attenuation between the normal liver parenchyma and 
CRLM is highest in the arterial phase (Figure 5). This may 
be explained by the unique sensitivity of IM in detecting 
the content of contrast medium in the tissue. 
The difference in the signal between structures is the 
most important factor that allows for lesion identifica-
tion. In an early work by Robinson et al., pure 80 kVp 
images acquired using a dual-source dual-energy scanner 
demonstrated higher attenuation differences between he-
patic metastases and the normal liver parenchyma than 
120 kVp images [24]. In our study, the highest differences 
between the liver parenchyma and metastases were not-
ed on iodine maps, 40 keV images, and 140 keV images 
(Figure 4). Since IM has also superior objective image 
quality, it seems to be the best reconstruction mode for 
diagnosing CRLM. Interestingly, IM was the only image 
type in which the arterial phase was more sensitive in 
detecting metastases than the portal phase. This may be 
explained by a unique sensitivity of IM to the content of 
iodine in the tissues. One might thus ask the question of 
whether the arterial phase can also be sufficient for di-
agnosis, which would significantly reduce radiation ex-
posure. The above-described technical advantages of IM 
and monoenergetic reconstructions are in line with the 
most important result of our study, namely that DECT 
can reveal more metastases than conventional CT, because 
the precise determination of the cancer dissemination is 
essential for surgery planning. 
The study has some limitations that have to be ad-
dressed. First, because the study was preliminary, a small 
number of participants were included. Although we 
found some advantages of DECT in imaging for CRLM, 
these findings should to be confirmed in a larger sample. 
Second, only one contrast medium at a low concentra-
tion was tested. Because iodine maps most effectively 
depict the differences in enhancement between the nor-
mal parenchyma and metastases, it would be valuable to 
investigate the performance of contrast media at higher 
concentrations. Third, no dose reduction strategies were 
applied in the study. Potentially, iterative reconstruction 
would have allowed for dose reduction to a level close to 
that associated with conventional CT. However, the aim 
of our study was to test DECT reconstructions, and the 
effect of dose reduction may be investigated in another 
study. Finally, there was no objective reference method 
established to objectively measure the diagnostic value 
of DECT for the determination of hepatic CRC involve-
ment. Therefore, further studies are being conducted 
with IOUS as a reference method to precisely meas-
ure the diagnostic performance of DECT in revealing 
CRLM. 
Conclusions
DECT seems to be a promising tool for imaging of CRLM. 
Iodine maps and low-photon energy reconstructions pres-
ent the highest differences in contrast between metastases 
and the normal liver parenchyma. Larger studies are nec-
essary to establish the role of DECT in determining liver 
involvement in colorectal cancer.
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